Abstract
Nuclear spin relaxation (NSR) is a powerful approach for studying dynamics at the ps-ns timescale, and is typically used to characterize fundamental biophysical phenomena such as bond vibrations and fluctuations, which affect the activity of the molecule in question. Here, this chapter will look to the application of NSR to study peptides, which are short chains of amino acids and have shown promise as modalities in drug design. This chapter will begin with a brief description of theoretical and practical aspects related to the use of NSR, such as experimental considerations during data acquisition and processing. As an example of this approach for studying peptide dynamics, this chapter will step through a case study that examines the effect of backbone cyclization on the dynamics of polycyclic disulfide-rich peptides. This case study will focus on a cyclic and linear variant of a promising drug scaffold isolated from sunflower seeds called SFTI-1 (sunflower trypsin inhibitor-1), which is a naturally backbone-cyclic peptide that comprises one cross-bracing disulfide bond.
References
Kleckner IR, Foster MP. An introduction to NMR-based approaches for measuring protein dynamics. Biochim Biophys Acta. 2011;1814:942–68.
Palmer 3rd AG. A dynamic look backward and forward. J Magn Reson. 2016;266:73–80.
Palmer 3rd AG. Nmr probes of molecular dynamics: overview and comparison with other techniques. Annu Rev Biophys Biomol Struct. 2001;30:129–55.
Rule GS, Hitchens TK. Nuclear Spin Relaxation and Molecular Dynamics. In: Fundamentals of Protein NMR Spectroscopy. Netherlands: Springer; 2006. p. 431–74.
Choy WY, Kay LE. Probing residual interactions in unfolded protein states using NMR spin relaxation techniques: an application to delta131delta. J Am Chem Soc. 2003;125:11988–92.
Horne J, d'Auvergne EJ, Coles M, Velkov T, Chin Y, Charman WN, Prankerd R, Gooley PR, Scanlon MJ. Probing the flexibility of the DsbA oxidoreductase from Vibrio cholerae--a 15N - 1H heteronuclear NMR relaxation analysis of oxidized and reduced forms of DsbA. J Mol Biol. 2007;371:703–16.
Craik DJ, Fairlie DP, Liras S, Price D. The future of peptide-based drugs. Chem Biol Drug Des. 2013;81:136–47.
Brady RM, Baell JB, Norton RS. Strategies for the development of conotoxins as new therapeutic leads. Mar Drugs. 2013;11:2293–313.
Daly NL, Seymour J, Wilson D. Exploring the therapeutic potential of jellyfish venom. Future Med Chem. 2014;6:1715–24.
Nguyen LT, Haney EF, Vogel HJ. The expanding scope of antimicrobial peptide structures and their modes of action. Trends Biotechnol. 2011;29:464–72.
Porter CJ, Matthews JM, Mackay JP, Pursglove SE, Schmidberger JW, Leedman PJ, Pero SC, Krag DN, Wilce MC, Wilce JA. Grb7 SH2 domain structure and interactions with a cyclic peptide inhibitor of cancer cell migration and proliferation. BMC Struct Biol. 2007;7:58.
Wang G, Drinkwater N, Drew DR, MacRaild CA, Chalmers DK, Mohanty B, Lim SS, Anders RF, Beeson JG, Thompson PE, McGowan S, Simpson JS, Norton RS, Scanlon MJ. Structure-Activity Studies of beta-Hairpin Peptide Inhibitors of the Plasmodium falciparum AMA1-RON2 Interaction. J Mol Biol. 2016;428:3986–98.
Strandberg E, Horn D, Reisser S, Zerweck J, Wadhwani P, Ulrich AS. 2H-NMR and MD Simulations Reveal Membrane-Bound Conformation of Magainin 2 and Its Synergy with PGLa. Biophys J. 2016;111:2149–61.
Klint JK, Chin YK, Mobli M. Rational Engineering Defines a Molecular Switch That Is Essential for Activity of Spider-Venom Peptides against the Analgesics Target NaV1.7. Mol Pharmacol. 2015;88:1002–10.
Korzhnev DM, Bocharov EV, Zhuravlyova AV, Orekhov VY, Ovchinnikova TV, Billeter M, Arseniev AS. Backbone dynamics of the channel-forming antibiotic zervamicin IIB studied by 15N NMR relaxation. FEBS Lett. 2001;495:52–5.
Conibear AC, Wang CK, Bi T, Rosengren KJ, Camarero JA, Craik DJ. Insights into the molecular flexibility of theta-defensins by NMR relaxation analysis. J Phys Chem B. 2014;118:14257–66.
Rovo P, Straner P, Lang A, Bartha I, Huszar K, Nyitray L, Perczel A. Structural insights into the Trp-cage folding intermediate formation. Chemistry. 2013;19:2628–40.
Goldenberg DP, Koehn RE, Gilbert DE, Wagner G. Solution structure and backbone dynamics of an omega-conotoxin precursor. Protein Sci. 2001;10:538–50.
Peto H, Stott K, Sunde M, Broadhurst RW. Backbone dynamics of oxidised and reduced forms of human atrial natriuretic peptide. J Struct Biol. 2004;148:214–25.
Rogne P, Ozdowy P, Richter C, Saxena K, Schwalbe H, Kuhn LT. Atomic-level structure characterization of an ultrafast folding mini-protein denatured state. PLoS One. 2012;7:e41301.
Rawat A, Kumar D. NMR investigations of structural and dynamics features of natively unstructured drug peptide - salmon calcitonin: implication to rational design of potent sCT analogs. J Pept Sci. 2013;19:33–45.
Song J, Vranken W, Xu P, Gingras R, Noyce RS, Yu Z, Shen SH, Ni F. Solution structure and backbone dynamics of the functional cytoplasmic subdomain of human ephrin B2, a cell-surface ligand with bidirectional signaling properties. Biochemistry. 2002;41:10942–9.
Daly NL, Thorstholm L, Greenwood KP, King GJ, Rosengren KJ, Heras B, Martin JL, Craik DJ. Structural insights into the role of the cyclic backbone in a squash trypsin inhibitor. J Biol Chem. 2013;288:36141–8.
Sher I, Chang SC, Li Y, Chhabra S, Palmer 3rd AG, Norton RS, Chill JH. Conformational flexibility in the binding surface of the potassium channel blocker ShK. Chembiochem. 2014;15:2402–10.
Saez NJ, Mobli M, Bieri M, Chassagnon IR, Malde AK, Gamsjaeger R, Mark AE, Gooley PR, Rash LD, King GF. Mol Pharmacol. 2011;80:796–808.
Yan Y, Wang C. J Mol Biol. 2006;364:853–62.
Shalom-Elazari H, Zazrin-Greenspon H, Shaked H, Chill JH. Biochim Biophys Acta. 2014;1838:2919–28.
de Medeiros LN, Angeli R, Sarzedas CG, Barreto-Bergter E, Valente AP, Kurtenbach E, Almeida FC. Biochim Biophys Acta. 2010;1798:105–13.
Bader R, Bettio A, Beck-Sickinger AG, Zerbe O. J Mol Biol. 2001;305:307–29.
Ingolfsson HI, Li Y, Vostrikov VV, Gu H, Hinton JF, Koeppe 2nd RE, Roux B, OS Andersen. J Phys Chem B. 2011;115:7417–26.
Yushmanov VE, Mandal PK, Liu Z, Tang P, Xu Y. Biochemistry. 2003;42:3989–95.
Campbell AP, Spyracopoulos L, Wong WY, Irvin RT, Sykes BD. Biochemistry. 2003;42:11334–46.
Wang M, Prorok M, Castellino FJ. Biophys J. 2010;99:302–12.
Puttamadappa SS, Jagadish K, Shekhtman A, Camarero JA. Angew Chem Int Ed Eng. 2010;49:7030–4.
De Paula VS, Gomes NS, Lima LG, Miyamoto CA, Monteiro RQ, Almeida FC, Valente AP. J Mol Biol. 2013;425:4479–95.
Bobby R, Medini K, Neudecker P, Lee TV, Brimble MA, McDonald FJ, Lott JS, Dingley AJ. Biochim Biophys Acta. 2013;1834:1632–41.
Lipari G, Szabo A. J Am Chem Soc. 1982;104:4546–59.
Lipari G, Szabo A. J Am Chem Soc. 1982;104:4559–70.
Meirovitch E, Shapiro YE, Polimeno A, Freed JH. Prog Nucl Magn Reson Spectrosc. 2010;56:360–405.
Clore GM, Szabo A, Bax A, Kay LE, Driscoll PC, Gronenborn AM. J Am Chem Soc. 1990;112:4989–91.
Schurr JM, Babcock HP, Fujimoto BS. J Magn Reson. 1994;105:211–24.
Allerhand A, Doddrell D, Glushko V, Cochran DW, Wenkert E, Lawson PJ, Gurd FR. J Am Chem Soc. 1971;93:544–6.
Wagner G. Q Rev Biophys. 1983;16:1–57.
Nirmala NR, Wagner G. J Am Chem Soc. 1988;110:7557–8.
Price WS. NMR diffusometry. In: Webb GA, editor. Modern magnetic resonance. 2006 Dordrecht: Springer. p. 109–15.
Wang CK, Northfield SE, Swedberg JE, Harvey PJ, Mathiowetz AM, Price DA, Liras S, Craik DJ. J Phys Chem B. 2014;118:11129–36.
Mandel AM, Akke M, Palmer 3rd AG. J Mol Biol. 1995;246:144–63.
Palmer 3rd AG, Rance M, Wright PE. J Am Chem Soc. 1991;113:4371–80.
d'Auvergne EJ, Gooley PR. J Biomol NMR. 2008;40:107–19.
d'Auvergne EJ, Gooley PR. J Biomol NMR. 2008;40:121–33.
Wang CK, Swedberg JE, Northfield SE, Craik DJ. J Phys Chem B. 2015;119:15821–30.
d'Auvergne EJ, Gooley PR. J Biomol NMR. 2003;25:25–39.
Clark RJ, Jensen J, Nevin ST, Callaghan BP, Adams DJ, Craik DJ. Angew Chem Int Ed Eng. 2010;49:6545–8.
Wang CK, Northfield SE, Colless B, Chaousis S, Hamernig I, Lohman RJ, Nielsen DS, Schroeder CI, Liras S, Price DA, Fairlie DP, Craik DJ. Proc Natl Acad Sci USA. 2014;111:17504–9.
Zorzi A, Deyle K, Heinis C. Curr Opin Chem Biol. 2017;38:24–9.
Veber DF, Freidlinger RM, Perlow DS, Paleveda Jr WJ, Holly FW, Strachan RG, Nutt RF, Arison BH, Homnick C, Randall WC, Glitzer MS, Saperstein R, Hirschmann R. Nature. 1981;292:55–8.
Luckett S, Garcia RS, Barker JJ, Konarev AV, Shewry PR, Clarke AR, Brady RL. J Mol Biol. 1999;290:525–33.
Northfield SE, Wang CK, Schroeder CI, Durek T, Kan MW, Swedberg JE, Craik DJ. Eur J Med Chem. 2014;77:248–57.
Wang CK, King GJ, Northfield SE, Ojeda PG, Craik DJ. Angew Chem Int Ed Eng. 2014;53:11236–41.
Ortega A, Amoros D, Garcia de la Torre J. Biophys J. 2011;101:892–8.
Vranken WF, Boucher W, Stevens TJ, Fogh RH, Pajon A, Llinas M, Ulrich EL, Markley JL, Ionides J, Laue ED. Proteins. 2005;59:687–96.
Korsinczky ML, Schirra HJ, Rosengren KJ, West J, Condie BA, Otvos L, Anderson MA, Craik DJ. J Mol Biol. 2001;311:579–91.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this entry
Cite this entry
Wang, C.K. (2017). NMR Relaxation Analysis of Pharmaceutically Active Peptides. In: Webb, G. (eds) Modern Magnetic Resonance. Springer, Cham. https://doi.org/10.1007/978-3-319-28275-6_115-1
Download citation
DOI: https://doi.org/10.1007/978-3-319-28275-6_115-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-28275-6
Online ISBN: 978-3-319-28275-6
eBook Packages: Springer Reference Chemistry and Mat. ScienceReference Module Physical and Materials ScienceReference Module Chemistry, Materials and Physics